Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefdinir vs Cephalexin in Uncomplicated Skin Infections
NCT00234949Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2005
- Modality
- Reversible Covalent Inhibitors
01
Overview
Phase 4, randomised, single-blind trial of cefdinir in skin and skin structure infections (SSSIs) (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Clinical cure rate. Started Mar 2005; status: completed.
02
Drugs
cefdinir
03
Conditions
skin and skin structure infections (SSSIs)
Beyond the preview
Go deeper on NCT00234949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234949.